About Timothy Garnett
Form D filings for Carmot Therapeutics from 2022 to 2023 list Timothy Garnett as director.
Timothy Garnett first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Timothy Garnett in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Timothy Garnett works with at each company, as listed on that company's latest Form D.
Carmot Therapeutics Inc. · Form D, Jun 6, 2023
AD
Anne Phillips, M.D.
Director
TK
Tim Kutzkey
Director
PS
Peter Svennilson
Director
AT
Aetna Wun Trombley
Director
SD
Stig Hansen, Ph.D.
Director
HT
Heather Turner
Chief Executive Officer and director